Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 37951-38000 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05972343
COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients
N/ARecruiting
100 participants
Started: Jul 26, 2023 · Completed: Jul 31, 2031
2 conditions1 sponsor1 location
NCT05766631
Treating Polysubstance Use Using a Novel Digital Technology
PHASE3Recruiting
240 participants
Started: Jul 26, 2023 · Completed: Sep 29, 2027
4 conditions2 sponsors5 locations
NCT05696782
Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
PHASE2Recruiting
28 participants
Started: Jul 26, 2023 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT05924971
Aspirin for Postpartum Patients With Preeclampsia
PHASE2Recruiting
86 participants
Started: Jul 26, 2023 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT05849753
Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes
N/ARecruiting
50 participants
Started: Jul 26, 2023 · Completed: Mar 30, 2026
4 conditions2 sponsors2 locations
NCT05855811
PREventing Second Cancers With DOSTARlimab
PHASE2Recruiting
400 participants
Started: Jul 26, 2023 · Completed: Mar 26, 2029
3 conditions2 sponsors5 locations
NCT05783765
Food Genetics Behavior Study
NARecruiting
158 participants
Started: Jul 26, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor1 location
NCT05963217
Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL
PHASE1Recruiting
19 participants
Started: Jul 26, 2023 · Completed: May 30, 2026
3 conditions2 sponsors1 location
NCT05970237
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
N/ARecruiting
9,000 participants
Started: Jul 26, 2023 · Completed: Oct 21, 2025
2 conditions1 sponsor1 location
NCT05842785
TSN222 in Subjects With Advanced Solid Tumors or Lymphomas
PHASE1/PHASE2Recruiting
162 participants
Started: Jul 26, 2023 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT06196190
Prognostic Value of Conization and Negative HPV After Conization in AIS and Early Stage Cervical Cancer
N/ARecruiting
200 participants
Started: Jul 26, 2023 · Completed: Jul 1, 2028
2 conditions1 sponsor1 location
NCT05931887
Evaluation of the Novel Silq ClearTract Catheter in Patients With Chronic Urinary Retention
NARecruiting
200 participants
Started: Jul 26, 2023 · Completed: Jul 26, 2025
4 conditions1 sponsor1 location
NCT05779449
Targeting the Gut Dysbiosis to Treat Inflammation-driven Synaptopathy in MS
NARecruiting
100 participants
Started: Jul 26, 2023 · Completed: May 1, 2026
1 condition2 sponsors1 location
NCT05909267
Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation
NARecruiting
165 participants
Started: Jul 26, 2023 · Completed: Oct 31, 2025
1 condition5 sponsors1 location
NCT04663152
Integrated Navigation Services for Treatment Adherence, Counseling, and Research
NARecruiting
10 participants
Started: Jul 26, 2023 · Completed: May 31, 2027
1 condition2 sponsors1 location
NCT05680922
DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer
PHASE1Recruiting
41 participants
Started: Jul 26, 2023 · Completed: Mar 31, 2028
2 conditions1 sponsor4 locations
NCT05955261
A Study of Venetoclax in Combination With Conventional Chemotherapy in Pediatric Patients With Acute Myeloid Leukemia
PHASE2Recruiting
70 participants
Started: Jul 25, 2023 · Completed: Mar 31, 2034
1 condition2 sponsors9 locations
NCT06272617
Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
NARecruiting
138 participants
Started: Jul 25, 2023 · Completed: Jul 24, 2025
2 conditions2 sponsors1 location
NCT04677647
OurChild: A Health IT Solution to Reduce Minority Health Disparities
NARecruiting
254 participants
Started: Jul 25, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05798520
A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)
PHASE2Recruiting
275 participants
Started: Jul 25, 2023 · Completed: Sep 7, 2027
1 condition1 sponsor77 locations
NCT06983054
DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study, a Randomized, Placebo-controlled, Cross-over Study With Ertugliflozin in People With Type 2 Diabetes
PHASE4Recruiting
34 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors2 locations
NCT06981676
The Developmental Origins of Obesity
NARecruiting
160 participants
Started: Jul 25, 2023 · Completed: Mar 30, 2027
2 conditions1 sponsor1 location
NCT05955105
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
PHASE1/PHASE2Recruiting
200 participants
Started: Jul 25, 2023 · Completed: Jul 24, 2026
10 conditions1 sponsor1 location
NCT05828810
CLinical Evaluation of ANtiseptic Skin Preparation in Revision Total Joint Arthroplasty of the Hip and Knee
NARecruiting
400 participants
Started: Jul 25, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor3 locations
NCT05721937
A Study of How Safe Abrocitinib (CIBINQO) is in Pregnant Women and Their Offspring
N/ARecruiting
400 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05666726
State-dependent Interoception, Value-based Decision-making, and Introspection
NARecruiting
900 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2029
5 conditions1 sponsor1 location
NCT07091162
EValuation Of poLygenic Scores and CT imAging In Risk Factor Modification in Patients With diabEtes
NARecruiting
90 participants
Started: Jul 25, 2023 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT04691817
Tocilizumab and Atezolizumab in Adults With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Refractory to 1st Line Immune Checkpoint Inhibitor-Based Therapy
PHASE1/PHASE2Recruiting
28 participants
Started: Jul 25, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05906589
Exploring Mechanism of Action of Dietary Fibre on the Gut Microbiota and Metabolites
NARecruiting
42 participants
Started: Jul 25, 2023 · Completed: May 31, 2025
2 conditions1 sponsor1 location
NCT05852925
Evaluation of Tasso+ Blood Self-Collection for Clinical Diagnostic Assessment of Various Biomarkers
NARecruiting
2,500 participants
Started: Jul 25, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT04289571
Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease
PHASE1Recruiting
165 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2030
2 conditions1 sponsor2 locations
NCT06243640
Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
PHASE3Recruiting
504 participants
Started: Jul 25, 2023 · Completed: Jun 30, 2027
1 condition2 sponsors1 location
NCT06139419
The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC
PHASE2Recruiting
114 participants
Started: Jul 25, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05547048
Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women
PHASE4Recruiting
250 participants
Started: Jul 25, 2023 · Completed: Apr 1, 2027
3 conditions2 sponsors2 locations
NCT05353530
IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
PHASE1Recruiting
39 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2042
2 conditions2 sponsors1 location
NCT05939570
DOSC and Association With Neighborhood Opportunity: Phase II
N/ARecruiting
30 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06013761
IF-MCT 16:8: Investigating the Influence of Intermittent Fasting With and Without MCTs in Patients With Drug-resistant Epilepsy
NARecruiting
28 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05725291
AMT-116 in Patients With Advanced Solid Tumors
PHASE1Recruiting
80 participants
Started: Jul 25, 2023 · Completed: Dec 30, 2026
1 condition1 sponsor10 locations
NCT05845138
A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.
PHASE1/PHASE2Recruiting
116 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor9 locations
NCT06219213
Glyceryl Eicosapentaenoate Based Topic Products As an Irritant-free Cream and Serum for Hydration of Sensitive Skin
NARecruiting
33 participants
Started: Jul 25, 2023 · Completed: Aug 7, 2025
1 condition2 sponsors1 location
NCT05630053
Cemented vs Cementless Persona Keel RCT
NARecruiting
300 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2032
9 conditions1 sponsor8 locations
NCT05520255
18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028
PHASE3Recruiting
2,800 participants
Started: Jul 25, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor1 location
NCT05875870
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
NARecruiting
200 participants
Started: Jul 24, 2023 · Completed: May 15, 2028
2 conditions2 sponsors1 location
NCT05748834
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
PHASE2Recruiting
36 participants
Started: Jul 24, 2023 · Completed: Jul 31, 2026
1 condition3 sponsors8 locations
NCT05888454
Integrative Group Program for Type 2 Diabetes Mellitus (T2DM)
NARecruiting
120 participants
Started: Jul 24, 2023 · Completed: Jul 31, 2024
1 condition3 sponsors2 locations
NCT05639413
A Clinical-biological Prospective Cohort of Patients With BRAFV600E-mutated Metastatic Colorectal Cancer
NARecruiting
400 participants
Started: Jul 24, 2023 · Completed: Jul 31, 2028
2 conditions2 sponsors45 locations
NCT05835466
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
PHASE2Recruiting
26 participants
Started: Jul 24, 2023 · Completed: Dec 31, 2028
3 conditions2 sponsors9 locations
NCT06152835
The BuKoBc Project: Building a Deeper Knowledge on Breast Milk Composition
N/ARecruiting
100 participants
Started: Jul 24, 2023 · Completed: Jul 24, 2026
1 condition1 sponsor1 location
NCT06085365
Effects of Immunonutrition on the Improvement of Postoperative Adjuvant Chemotherapy Related Adverse Reactions in Patients With Gastrointestinal Tumors
PHASE3Recruiting
324 participants
Started: Jul 24, 2023 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05173272
Induction Chemotherapy Combined With Immunotherapy Followed by Concurrent Chemoradiation in Advanced Cervical Cancer
PHASE3Recruiting
286 participants
Started: Jul 24, 2023 · Completed: Dec 28, 2028
1 condition1 sponsor1 location